These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11892075)

  • 1. Recombinant allergens/allergen standardization.
    Løwenstein H; Larsen JN
    Curr Allergy Asthma Rep; 2001 Sep; 1(5):474-9. PubMed ID: 11892075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F
    Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant proteins and peptides as diagnostic and therapeutic reagents for arthropod allergies.
    Ramos JD; Valmonte GR; de Guia RM
    Protein Pept Lett; 2007; 14(10):992-1002. PubMed ID: 18220997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant allergens: what does the future hold?
    Valenta R; Niespodziana K; Focke-Tejkl M; Marth K; Huber H; Neubauer A; Niederberger V
    J Allergy Clin Immunol; 2011 Apr; 127(4):860-4. PubMed ID: 21458656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant allergens for pollen immunotherapy.
    Wallner M; Pichler U; Ferreira F
    Immunotherapy; 2013 Dec; 5(12):1323-38. PubMed ID: 24283843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of Allergen Extracts.
    Larsen JN; Dreborg S
    Methods Mol Biol; 2019; 2020():63-76. PubMed ID: 31177492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Japanese Society of Allergology Task Force Report on standardization of house dust mite allergen vaccines].
    Takai T; Okamoto Y; Okubo K; Nagata M; Sakaguchi M; Fukutomi Y; Saito A; Yasueda H; Masuyama K
    Arerugi; 2014 Nov; 63(9):1229-40. PubMed ID: 25492878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of different recombinant isoforms of grass group-V allergens (timothy grass pollen) isolated by low-stringency cDNA hybridization--antibody binding capacity and allergenic activity.
    Gehlhar K; Petersen A; Schramm G; Becker WM; Schlaak M; Bufe A
    Eur J Biochem; 1997 Jul; 247(1):217-23. PubMed ID: 9249029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interests of recombinant allergens in the practice of allergy].
    Karoui O; Leimgruber A; Spertini F
    Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for converting allergens into hypoallergenic vaccine candidates.
    Vrtala S; Focke-Tejkl M; Swoboda I; Kraft D; Valenta R
    Methods; 2004 Mar; 32(3):313-20. PubMed ID: 14962766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current state of recombinant allergens for immunotherapy.
    Pauli G; Malling HJ
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of the 18-kDa major apple allergen and comparison with the major birch pollen allergen (Bet v I).
    Vieths S; Janek K; Aulepp H; Petersen A
    Allergy; 1995 May; 50(5):421-30. PubMed ID: 7573831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant allergens for diagnosis and therapy of allergic disease.
    Chapman MD; Smith AM; Vailes LD; Arruda LK; Dhanaraj V; Pomés A
    J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of allergen standardization.
    Jeong KY; Hong CS; Lee JS; Park JW
    Yonsei Med J; 2011 May; 52(3):393-400. PubMed ID: 21488181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of allergen extracts.
    Larsen JN; Dreborg S
    Methods Mol Med; 2008; 138():133-45. PubMed ID: 18612605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
    Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
    J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.